- Home
- ACHV vs ZTEK Comparison
ACHV vs ZTEK Comparison
Compare ACHV & ZTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACHV
- ZTEK
- Stock Information
- Founded
- ACHV N/A
- ZTEK 2008
- Country
- ACHV Canada
- ZTEK Canada
- Employees
- ACHV N/A
- ZTEK N/A
- Industry
- ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
- ZTEK Major Chemicals
- Sector
- ACHV Health Care
- ZTEK Industrials
- Exchange
- ACHV Nasdaq
- ZTEK Nasdaq
- Market Cap
- ACHV 126.9M
- ZTEK 122.0M
- IPO Year
- ACHV N/A
- ZTEK N/A
- Fundamental
- Price
- ACHV $3.17
- ZTEK $1.02
- Analyst Decision
- ACHV Strong Buy
- ZTEK
- Analyst Count
- ACHV 5
- ZTEK 0
- Target Price
- ACHV $14.80
- ZTEK N/A
- AVG Volume (30 Days)
- ACHV 229.0K
- ZTEK 35.9K
- Earning Date
- ACHV 03-27-2025
- ZTEK 03-04-2025
- Dividend Yield
- ACHV N/A
- ZTEK N/A
- EPS Growth
- ACHV N/A
- ZTEK N/A
- EPS
- ACHV N/A
- ZTEK N/A
- Revenue
- ACHV N/A
- ZTEK $44,936.00
- Revenue This Year
- ACHV N/A
- ZTEK N/A
- Revenue Next Year
- ACHV N/A
- ZTEK N/A
- P/E Ratio
- ACHV N/A
- ZTEK N/A
- Revenue Growth
- ACHV N/A
- ZTEK 92.38
- 52 Week Low
- ACHV $2.84
- ZTEK $0.50
- 52 Week High
- ACHV $5.59
- ZTEK $1.34
- Technical
- Relative Strength Index (RSI)
- ACHV 44.06
- ZTEK 42.80
- Support Level
- ACHV $3.18
- ZTEK $1.02
- Resistance Level
- ACHV $3.59
- ZTEK $1.20
- Average True Range (ATR)
- ACHV 0.21
- ZTEK 0.08
- MACD
- ACHV 0.01
- ZTEK -0.01
- Stochastic Oscillator
- ACHV 19.48
- ZTEK 18.18
About ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.
About ZTEK Zentek Ltd.
Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.